Early report on the severity of COVID‐19 in hematologic patients infected with the SARS‐CoV2 omicron variant

INTRODUCTION: Patients with hematologic disease are at high risk of morbidity and mortality from COVID‐19 due to disease‐inherent and therapy‐related immunodeficiency. Whether infection with the SARS‐CoV2 omicron variant leads to attenuated disease severity in these patients is currently unknown. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullrich, Fabian, Hanoun, Christine, Turki, Amin T., Liebregts, Tobias, Breuckmann, Katharina, Alashkar, Ferras, Reinhardt, Hans Christian, von Tresckow, Bastian, von Tresckow, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350268/
https://www.ncbi.nlm.nih.gov/pubmed/35751531
http://dx.doi.org/10.1111/ejh.13818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350268/
https://www.ncbi.nlm.nih.gov/pubmed/35751531
http://dx.doi.org/10.1111/ejh.13818

Ejemplares similares